ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 713,98
-0,28%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. RespireRx Pharmaceuticals Inc (PK) (RSPI)

  7. RespireRx Pharmaceuticals Inc (PK) (RSPI) Actualités

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:RSPI
DateHeureSourceTitreSymboleSociété
02/02/202414h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
17/11/202322h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/11/202322h05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
13/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
22/05/202322h17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/05/202322h08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/04/202220h17Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
31/03/202222h11Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/01/202222h32Edgar (US Regulatory)Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
01/12/202122h07Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
09/08/202115h16Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
19/02/202122h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
30/10/202016h19Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
29/10/202011h07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
20/10/202022h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/10/202012h48Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
02/10/202021h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/09/202022h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
12/08/202019h14Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
04/08/202020h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/04/202022h16Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
24/03/202018h51Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
20/12/201815h32Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
29/06/201822h46Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
08/09/201714h15MarketwiredRespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw ConferenceUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
25/08/201716h54MarketwiredRespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides UpdateUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/06/201714h45MarketwiredRespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap ConferenceUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
06/06/201723h00MarketwiredRespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MAUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/02/201714h30MarketwiredRespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
06/01/201714h15MarketwiredRespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:RSPI

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
DG
Vinci
EU
RNO
Renault
COIN
ETHUSD
Ethereum
EU
PX1
CAC 40
NYSE
MCD
McDonalds
EU
LR
Legrand
FTSE
UKX
FTSE 100
EU
AF
Air FranceKLM
EU
EN
Bouygues
EU
RI
Pernod Ricard
NASDAQ
AMZN
Amazon.com
EU
GLE
Societe Generale
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés